The Leloir Pathway of Galactose Metabolism – A Novel Therapeutic Target for Hepatocellular Carcinoma
Manshu Tang(University of Utah), Kent Lai(University of Utah)
Cited by 57
Related Papers
AAV9-based PMM2 gene replacement augments PMM2 expression and improves glycosylation in primary fibroblasts of patients with phosphomannomutase 2 deficiency (PMM2-CDG)
|Molecular Genetics and Metabolism Reports|2023|9
Harnessing the Power of Purple Sweet Potato Color and Myo-Inositol to Treat Classic Galactosemia
|International Journal of Molecular Sciences|2022|8
AAV-based gene replacement reverses Neurexin-2 downregulation in the cerebellum of a mouse model of phosphomannomutase 2 deficiency (PMM2-CDG)
|bioRxiv (Cold Spring Harbor Laboratory)|2025|0